Erin Zagadailov
- Oncology
- Genetics top 10%
- Hematology top 10%
- Pathology and Forensic Medicine
- Physiology
- Co-authors
- Alan L. ShieldsMichael J. FineMehul DalalTim IllidgePaul J. BröckelmannEduard J. van BeersBrian SealAndreas Glenthøj
- Topics
- Lymphoma Diagnosis and Treatment (11 papers)Erythrocyte Function and Pathophysiology (9 papers)Blood disorders and treatments (5 papers)
- Cited by
- GeneticsHematologyDermatology
- Journals
- New England Journal of MedicineSHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Erin Zagadailov
29 papers receiving 331 citations
Peers
Comparison fields: 5 of 55
- Oncology 100
- Genetics 95
- Hematology 88
- Pathology and Forensic Medicine 76
- Physiology 74
Countries citing papers authored by Erin Zagadailov
This map shows the geographic impact of Erin Zagadailov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Zagadailov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Zagadailov more than expected).
Fields of papers citing papers by Erin Zagadailov
This network shows the impact of papers produced by Erin Zagadailov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Zagadailov. The network helps show where Erin Zagadailov may publish in the future.
Co-authorship network of co-authors of Erin Zagadailov
This figure shows the co-authorship network connecting the top 25 collaborators of Erin Zagadailov. A scholar is included among the top collaborators of Erin Zagadailov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Zagadailov. Erin Zagadailov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 31 | |
| 4 | 1 | |
| 5 | 28 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 12 | |
| 9 | 1 | |
| 10 | 17 | |
| 11 | 1 | |
| 12 | Real-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory Hodgkin lymphoma post autologous stem-cell transplantation. | 5 |
| 13 | 1 | |
| 14 | Brentuximab vedotin in patients who are ineligible for autologous stem cell transplant with relapsed or refractory Hodgkin lymphoma: a United Kingdom and Germany retrospective study. | 1 |
| 15 | 17 | |
| 16 | 1 | |
| 17 | 3 | |
| 18 | 1 | |
| 19 | 15 | |
| 20 | 3 |
About Erin Zagadailov
Erin Zagadailov is a scholar working on Hematology, Dermatology and Pathology and Forensic Medicine, having authored 31 papers that have together received 336 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), Erythrocyte Function and Pathophysiology (9 papers) and Blood disorders and treatments (5 papers). The work is most often cited by research in Genetics (95 citations), Hematology (88 citations) and Dermatology (46 citations). Erin Zagadailov has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Alan L. Shields, Michael J. Fine, Mehul Dalal, Tim Illidge, Paul J. Bröckelmann, Eduard J. van Beers, Brian Seal, Andreas Glenthøj, Ashish Gautam and Dirk Huebner. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.